SP

Susan Pond

Dr Pond has scientific and commercial background, having held executive positions in the biotechnology and pharmaceutical industry for 12 years, including as Chairman and Managing Director of Johnson & Johnson Research Pty Limited (2003 to 2009). Dr Pond has held many Board positions such as: Non-Executive Director and Chairman of AusBiotech Limited (2006 to 2008); Director of the Australian Nuclear Science and Technology Organisation (ANSTO) (2010 to 2014); Board member of Innovation Australia (2012 to 2015); and Vice President of the Academy of Technological Sciences and Engineering (ATSE) (2010 to 2015). She is Chair of Risk, Corporate Governance and R&D and Innovation Committees.

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
28/11/240785,15465,430N/A
27/11/24040,250N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
28/12/22
Issued
18,750$0.800$15,000Participation in share purchase plan
25/11/22
Issued
65,430$0.028$1,832Rights issue
25/11/22
Issued
130,859$0.030$3,925Rights issue
05/12/19
Exercise
109,049$0.050$5,452Exercise of options
05/12/19
Buy
109,049$0.050$5,452Exercise of options